Raymond Akers Jr. resigned as a director of Akers Biosciences Inc., effective May 29.
Akers Biosciences makes and sells rapid screening and testing products for the healthcare industry.
Akers Biosciences director resigns
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Raymond Akers Jr. resigned as a director of Akers Biosciences Inc., effective May 29.
Akers Biosciences makes and sells rapid screening and testing products for the healthcare industry.